参考文献

1.BJ Vakoc，RM Lanning，JA Tyrrell，et al.Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging.Nat Med，2009，15：1219-1223.

2.EB Brown，RB Campbell，Y Tsuzuki，et al.In vivo measurement of gene expression，angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy.Nat Med，2001，7：864-868.

3.RK Jain.Molecular regulation of vessel maturation.Nat Med，2003， 9：685-693.

4.P Baluk，H Hashizume，DM McDonald.Cellular abnormalities of blood vessels as targets in cancer.Curr Opin Genet Dev，2005，15：102-111.

5.JA Nagy，SH Chang，SC Shih，et al.Heterogeneity of the tumor vasculature.Semin Thromb Hemost，2010，36：321-331.

6.P Carmeliet，RK Jain，.Molecular mechanisms and clinical applications of angiogenesis.Nature，2011，473：298-307.

7.RK Jain.Normalizing tumor microenvironment to treat cancer：bench to bedside to biomarkers.J Clin Oncol，2013，31：2205-2218.

8.G Helmlinger，A Sckell，M Dellian，et al.Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism.Clin Cancer Res，2002，8：1284-1291.

9.GG Zhu，L Risteli，M Makinen，et al.Immunohistochemical study of typeⅠcollagen and typeⅠpN-collagen in benign and malignant ovarian neoplasms.Cancer，1995，75：1010-1017.

10.IJ Huijbers，M Iravani，S Popov，et al.A role for fibrillar collagen deposition and the collagen internalization receptor endo180 in glioma invasion.PLoS One，2010，5：9808.

11.WH Norton，J Ledin，H Grandel，et al.C.J.Neumann，HSPG synthesis by zebrafish Ext2 and Extl3 is required for Fgf10 signalling during limb development.Development，2005，132：4963-4973.

12.DT Butcher，T Alliston，VM Weaver.A tense situation：forcing tumour progression.Nat Rev Cancer，2009，9；108-122.

13.T Schatton，U Schutte，NY Frank，et al.Modulation of T-cell activation by malignant melanoma initiating cells.Cancer Res，2010， 70：697-708.

14.J Wei，J Barr，LY Kong，et al.Glioma-associated cancer-initiating cells induce immunosuppression.Clin Cancer Res，2010，16：461-473.

15.X Yu，H Li，X Ren.Interaction between regulatory T cells and cancer stem cells.Int J Cancer，2012 ，131：1491-1498.

16.S Yang，B Wang，C Guan，et al.Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer.J Leukoc Biol，2011，89：85-91.

17.C Werno，H Menrad，A Weigert，et al.Knockout of HIF-1alpha in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses.Carcinogenesis，2010，31：1863-1872.

18.M Jinushi，S Chiba，H Yoshiyama，et al.Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells.Proc Natl Acad Sci USA，2011，108：12425-12430.

19.R Hanayama，M Tanaka，K Miwa，et al.Identification of a factor that links apoptotic cells to phagocytes.Nature，2002，417：182-187.

20.M Jinushi，Y Nakazaki，M Dougan，et al.MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF.J Clin Invest，2007，117：1902-1913.

21.M Jinushi，M Sato，A Kanamoto，et al.Milk fat globule epidermal growth factor-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms.J Exp Med，2009，206：1317-1326.

22.M Jinushi，Y Nakazaki，DR Carrasco，et al.Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment.Cancer Res，2008，68：8889-8898.

23.L Du，H Wang，L He，et al.CD44 is of functional importance for colorectal cancer stem cells.Clin Cancer Res，2008，14：6751-6760.

24.D Naor，SB Wallach-Dayan，MA Zahalka，et al.Involvement of CD44，a molecule with a thousand faces，in cancer dissemination.Semin Cancer Biol，2008，18：260-267.

25.G Rao，H Wang，B Li，et al.Reciprocal interactions between tumor-associated macrophages and CD44-positive cancer cells via osteopontin/CD44 promote tumorigenicity in colorectal cancer.Clin Cancer Res，2013，19：785-797.

26.DK Irvin，E Jouanneau，G Duvall，et al.T cells enhance stem-like properties and conditional malignancy in gliomas.PLoS One，2010，5：e10974.

27.V Levina，AM Marrangoni，R DeMarco，et al.Drug-selected human lung cancer stem cells：cytokine network，tumorigenic and metastatic properties.PLoS One，2008，3：3077.

28.I Wertel，B Barczynski，J Kotarski.The role of dendritic cells in cytotoxic immune response regulation in ovarian cancer micro-environment.Front Biosci，2008，13：2177-2190.

29.R Kalluri，RA Weinberg.The basics of epithelial-mesenchymal transition.J Clin Invest，2009，119：1420-1428.

30.JP Thiery，H Acloque，RY Huang，et al.Epithelial-mesenchymal transitions in development and disease.Cell，2009，139：871-890.

31.SA Mani，W Guo，MJ Liao，et al.The epithelial-mesenchymal transition generates cells with properties of stem cells.Cell，2008，133：704-715.

32.K Polyak，RA Weinberg.Transitions between epithelial and mesenchymal states：acquisition of malignant and stem cell traits.Nat Rev Cancer，2009，9：265-273.

33.BE Lippitz.Cytokine patterns in patients with cancer：a systematic review.Lancet Oncol，2013，14：e218-228.

34.AP Morel，M Lievre，C Thomas，et al.Generation of breast cancer stem cells through epithelial-mesenchymal transition.PLoS One，2008，3：2888.

35.SM Cabarcas，LA Mathews，WL Farrar.The cancer stem cell niche—there goes the neighborhood? Int J Cancer，2011，129：2315-2327.

36.S Bao，Q Wu，S Sathornsumetee，et al.Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor.Cancer Res，2006，66：7843-7848.

37.C Folkins，Y Shaked，S Man，et al.Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1.Cancer Res，2009，69：7243-7251.

38.P Sansone，G Storci，S Tavolari，et al.IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland.J Clin Invest，2007，117：3988-4002.

39.H Wang，JD Lathia，Q Wu，et al.Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth.Stem Cells，2009，27：2393-2404.

40.JI Coward，H Kulbe.The role of interleukin-6 in gynaecological malignancies.Cytokine Growth Factor Rev，2012，23：333-342.

41.Z Wang，Y Li，FH Sarkar.Signaling mechanism（s）of reactive oxygen species in Epithelial-Mesenchymal Transition reminiscent of cancer stem cells in tumor progression.Curr Stem Cell Res Ther，2010，5：74-80.

42.N Aptsiauri，T Cabrera，R Mendez，et al.Role of altered expression of HLA classⅠ molecules in cancer progression.Adv Exp Med Biol，2007，601：123-131.

43.T Schatton，MH Frank.Antitumor immunity and cancer stem cells.Ann N Y Acad Sci，2009，1176：154-169.

44.A Wu，S Wiesner，J Xiao，et al.Expression of MHCⅠ and NK ligands on human CD133⁺ glioma cells：possible targets of immunotherapy.J Neurooncol，2007，83：121-131.

45.T Di Tomaso，S Mazzoleni，E Wang，et al.Immunobiological characterization of cancer stem cells isolated from glioblastoma patients.Clin Cancer Res，2010，16：800-813.

46.H Pandha，A Rigg，J John，et al.Loss of expression of antigen-presenting molecules in human pancreatic cancer and pancreatic cancer cell lines.Clin Exp Immunol，2007，148：127-135.

47.BT Kawasaki，T Mistree，EM Hurt，et al.Co-expression of the toleragenic glycoprotein，CD200，with markers for cancer stem cells.Biochem Biophys Res Commun，2007，364：778-782.

48.A Kretz-Rommel，F Qin，N Dakappagari，et al.CD200 expression on tumor cells suppresses antitumor immunity：new approaches to cancer immunotherapy.J Immunol，2007，178：5595-5605.

49.TP Rygiel，G Karnam，G Goverse，et al.CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor.Oncogene，2012，31：2979-2988.

50.J Yao，T Zhang，J Ren，et al.Effect of CD133/prominin-1 antisense oligodeoxynucleotide on in vitro growth characteristics of Huh-7 human hepatocarcinoma cells and U251 human glioma cells.Oncol Rep，2009，22：781-787.

51.J Ji，KL Black，JS Yu.Glioma stem cell research for the development of immunotherapy.Neurosurg Clin N Am，2010，21：159-166.

52.G Liu，X Yuan，Z Zeng，et al.Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma.Mol Cancer，2006，5：67.

53.L Jin，EM Lee，HS Ramshaw，et al.Monoclonal antibody-mediated targeting of CD123，IL-3 receptor alpha chain，eliminates human acute myeloid leukemic stem cells.Cell Stem Cell，2009，5：31-42.

54.Z Li，S Bao，Q Wu，et al.Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.Cancer Cell，2009，15：501-513.

55.JA Trapani，VR Sutton.Granzyme B：pro-apoptotic，antiviral and antitumor functions.Curr Opin Immunol，2003，15：533-543.

56.SA Rosenberg，NP Restifo，JC Yang，et al.Adoptive cell transfer：a clinical path to effective cancer immunotherapy.Nat Rev Cancer，2008，8：299-308.

57.M Todaro，MP Alea，AB Di Stefano，et al.Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.Cell Stem Cell，2007，1：389-402.

58.M Ahmadzadeh，A Felipe-Silva，B Heemskerk，et al.FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions.Blood，2008，112：4953-4960.

59.RA Clark，SJ Huang，GF Murphy，et al.Human squamous cell carcinomas evade the immune response by downregulation of vascular E-selectin and recruitment of regulatory T cells.J Exp Med，2008，205：2221-2234.

60.SG Piccirillo，BA Reynolds，N Zanetti，et al.Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.Nature，2006，444：761-765.

61.AG Jarnicki，J Lysaght，S Todryk，et al.Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor：influence of tumor environment on the induction of CD4+ and CD8+regulatory T cells.J Immunol，2006，177：896-904.

62.AN Barclay，MH Brown.The SIRP family of receptors and immune regulation.Nat Rev Immunol，2006，6：457-464.

63.S Jaiswal，CH Jamieson，WW Pang，et al.CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.Cell，2009，138：271-285.

64.R Majeti，MP Chao，AA Alizadeh，et al.CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.Cell，2009，138：286-299.

65.JB Sneddon，HH Zhen，K Montgomery，et al.Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation.Proc Natl Acad Sci U S A，2006，103：14842-14847.

66.N Taieb，M Maresca，XJ Guo，et al.The first extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motif.Cancer Lett，2009，278：164-173.

67.W Shen，K Stone，A Jales，et al.Inhibition of TLR activation and up-regulation of IL-1R-associated kinase-M expression by exogenous gangliosides.J Immunol，2008，180：4425-4432.

68.A Orimo，RA Weinberg.Stromal fibroblasts in cancer：a novel tumor-promoting cell type.Cell Cycle，2006，5：1597-1601.

69.CM Overall，O Kleifeld.Tumour microenvironment-opinion：validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.Nat Rev Cancer，2006，6：227-239.

70.A Taylor，J Verhagen，K Blaser，et al.Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta：the role of T regulatory cells.Immunology，2006，117：433-442.

71.M Di Ianni，B Del Papa，M De Ioanni，et al.Mesenchymal cells recruit and regulate T regulatory cells.Exp Hematol，2008，36：309-318.

72.C Calabrese，H Poppleton，M Kocak，et al.A perivascular niche for brain tumor stem cells.Cancer Cell，2007，11：69-82.

73.K Hatfield，A Ryningen，M Corbascio，et al.Microvascular endothelial cells increase proliferation and inhibit apoptosis of native human acute myelogenous leukemia blasts.Int J Cancer，2006，119：2313-2321.

74.M Huang，Y Li，H Zhang，et al.Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction.J Exp Clin Cancer Res，2010，29：80.

75.L，M Postovit，DE Abbott，SL Payne，et al.Hypoxia/reoxygenation：a dynamic regulator of lysyl oxidasefacilitated breast cancer migration.J Cell Biochem，2008，103：1369-1378.

76.R Bjerkvig，M Johansson，H Miletic，et al.Cancer stem cells and angiogenesis.Semin Cancer Biol，2009，19：279-284.

77.G Pietra，C Manzini，M Vitale，et al.Natural killer cells kill human melanoma cells with characteristics of cancer stem cells.Int Immunol，2009，21：793-801.

78.R Tallerico，M Todaro，S Di Franco，et al.Human NK cells selective targeting of colon cancer-initiating cells：a role for natural cytotoxicity receptors and MHC class Ⅰ molecules.J Immunol，2013，190：2381-2390.

79.M Todaro，M D′Asaro，N Caccamo，et al.Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes.J Immunol，2009，182：7287-7296.

80.S Girlanda，C Fortis，D Belloni，et al.MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.Cancer Res，2005，65：7502-7508.

81.S Inoda，Y Hirohashi，T Torigoe，et al.Cytotoxic T lymphocytes efficiently recognize human colon cancer stemlike cells.Am J Pathol，2011，178：1805-1813.

82.C Gedye，J Quirk，J Browning，et al.Cancer/testis antigens can be immunological targets in clonogenic CD133+melanoma cells.Cancer Immunol Immunother，2009，58：1635-1646.

83.N Ahmed，VS Salsman，Y Kew，et al.HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors.Clin Cancer Res，2010，16：474-485.

84.Q Xu，G Liu，X Yuan，et al.Antigen-specific T-cell response from dendritic cell vaccination using cancer stemlike cell-associated antigens.Stem Cells，27（2009）：1734-1740.

85.YM Yang，JW Chang.Current status and issues in cancer stem cell study.Cancer Invest，2008，26：741-755.

86.Z Gadhoum，J Delaunay，E Maquarre，et al.The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells.Leuk Lymphoma，2004，45：1501-1510.

87.LM Smith，A Nesterova，MC Ryan，et al.Carter，CD133/prominin-1 is a potential therapeutic target for antibodydrug conjugates in hepatocellular and gastric cancers.Br J Cancer，2008，99：100-109.

88.BJ Huntly，DG Gilliland.Leukaemia stem cells and the evolution of cancer-stem-cell research.Nat Rev Cancer，2005，5：311-321.

89.V Clement，P Sanchez，N de Tribolet，et al.HEDGEHOG-GLI1 signaling regulates human glioma growth，cancer stem cell self-renewal，and tumorigenicity.Curr Biol，2007，17：165-172.

90.RC Sainson，AL Harris.Anti-Dll4 therapy：can we block tumour growth by increasing angiogenesis？ Trends Mol Med，2007，13：389-395.

91.T Hoey，WC Yen，F Axelrod，et al.DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency.Cell Stem Cell，2009，5：168-177.

92.JB Sneddon，Z Werb.Location，location，location：the cancer stem cell niche.Cell Stem Cell，2007，1：607-611.

93.M Dean，T Fojo，S Bates，et al.Tumour stem cells and drug resistance.Nat Rev Cancer，2005，5：275-284.